The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE−/− and LDLr−/− mice by a mechanism that includes inflammatory pathways - Rakipovski, G; Rolin, B; Nøhr, J (JACC Basic Transl Sci, 2018)